Device and method for safe location and marking of a biopsy cavity

US9669113B1 · US · B1

Patent metadata
FieldValue
Publication numberUS-9669113-B1
Application numberUS-86928299-A
CountryUS
Kind codeB1
Filing dateDec 23, 1999
Priority dateDec 24, 1998
Publication dateJun 6, 2017
Grant dateJun 6, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Cavity and sentinel lymph node marking devices, marker delivery devices, and methods are disclosed. More particularly, upon insertion into a body, the cavity marking device and method enable one to determine the center, orientation, and periphery of the cavity by radiographic, mammography, echogenic, or other noninvasive imaging techniques. A composition and method are disclosed for locating the sentinel lymph node in a mammalian body to determine if cancerous cells have spread thereto. The composition is preferably a fluid composition consisting of a carrier fluid and some type of contrast agent; alternatively, the contrast agent may itself be a fluid and therefore not need a separate carrier fluid. This composition is capable of (1) deposition in or around a lesion and migration to and accumulation in the associated sentinel node, and (2) remote detection via any number of noninvasive techniques. Also disclosed is a method for remotely detecting the location of a sentinel node by (1) depositing a remotely detectable fluid in or around a lesion for migration to and accumulation in the associated sentinel node and (2) remotely detecting the location of that node with a minimum of trauma and toxicity to the patient. The composition and method may serve to mark a biopsy cavity, as well as mark the sentinel lymph node. The marking methods also may combine any of the features as described with the marking device and delivery device.

First claim

Opening claim text (preview).

We claim as our invention: 1. A delivery device for delivering a marking device to a target site, said delivery device comprising: an elongate member having a distal portion and a proximal portion with a lumen extending between the distal and proximal portions, said distal portion of said elongate member configured to seat the marking device and advance the marking device within said distal portion to the target site; an ejector coupled to said elongate member, said ejector configured to disengage the marking device from said distal portion; a marking device preloaded in said elongate member distal portion, for delivery through the lumen; wherein said marking device comprises a first component and a second component, the first component is a wound arrangement of bioabsorbable suture material and the second component is a unitary piece of metal forming a marker, wherein the second component is carried and supported by the wound arrangement of the first component, and wherein the wound arrangement of the first component includes multiple passes of the suture material through the second component to form a plurality of loops, each loop having a first end that extends from a first side of the second component and a second end that extends from a second side of the second component opposite the first side, wherein the plurality of loops comprises at least 10 loops forming a loosely would ball shape and wherein the marker is positioned at a geometric center of the ball shape. 2. A marking device comprising: a first component being a wound arrangement of bioabsorbable suture material; a second component being a unitary piece of metal forming a marker; and wherein the first component includes multiple passes of the suture material forming a body defined by the wound arrangement of the suture material with the second component carried and supported by the body, and wherein the wound arrangement of the first component includes multiple passes of the suture material through the second component to form a plurality of loops, each loop having a first end that extends from a first side of the second component and a second end that extends from a second side of the second component opposite the first side, wherein the plurality of loops comprises at least 10 loops forming a loosely would ball shape and wherein the marker is positioned at a geometric center of the ball shape. 3. A marking device comprising: a delivery device having an elongate member with a lumen; a first component being a bioabsorbable suture material; a second component being a unitary piece of metal forming a marker; and wherein the first component includes multiple passes of the suture material forming a wound arrangement of the suture material with the second component carried and supported by the wound arrangement, and wherein the wound arrangement of the first component includes multiple passes of the suture material through the second component to form a plurality of loops, each loop having a first end that extends from a first side of the second component and a second end that extends from a second side of the second component opposite the first side, wherein the plurality of loops comprises at least 10 loops forming a loosely would ball shape and wherein the marker is positioned at a geometric center of the ball shape. 4. A biopsy marking apparatus for marking a target site within the breast, the apparatus comprising: a delivery device having an elongate member with a lumen; an echogenic body comprising a wound arrangement of bioabsorbable material; and a radiopaque marker carried and supported within the wound arrangement of the echogenic body, the marker having a recognizable shape distinguishable from calcifications, wherein the wound arrangement of the first component includes multiple passes of a suture material through the radiopaque marker to form a plurality of loops, each loop having a first end that extends from a first side of the radiopaque marker and a second end that extends from a second side of the radiopaque marker opposite the first side, wherein the plurality of loops comprises at least 10 loops forming a loosely would ball shape and wherein the marker is positioned at a geometric center of the ball shape, wherein the echogenic body is disposed within the lumen of the delivery device and deployable from the delivery device to the target site.

Assignees

Inventors

Classifications

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9669113B1 cover?
Cavity and sentinel lymph node marking devices, marker delivery devices, and methods are disclosed. More particularly, upon insertion into a body, the cavity marking device and method enable one to determine the center, orientation, and periphery of the cavity by radiographic, mammography, echogenic, or other noninvasive imaging techniques. A composition and method are disclosed for locating th…
Who is the assignee on this patent?
Sirimanne D Laksen, Fawzi Natalie V, Sutton Douglas S, and 6 more
What technology area does this patent fall under?
Primary CPC classification A61B90/39. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Jun 06 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).